➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Mallinckrodt
McKinsey
Medtronic
Moodys
Harvard Business School
AstraZeneca

Last Updated: October 20, 2020

DrugPatentWatch Database Preview

Drugs in Development Information for Deslorelin

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What is the development status for investigational drug Deslorelin?

Deslorelin is an investigational drug.

There have been 5 clinical trials for Deslorelin. The most recent clinical trial was a Phase 2 trial, which was initiated on January 1st 1985.

The most common disease conditions in clinical trials are Growth Disorders, Puberty, Precocious, and Dwarfism. The leading clinical trial sponsors are Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), City of Hope Medical Center, and National Cancer Institute (NCI).

Recent Clinical Trials for Deslorelin
TitleSponsorPhase
Deslorelin Combined With Low-Dose Add-Back Estradiol and Testosterone in Preventing Breast Cancer in Premenopausal Women Who Are at High Risk for This DiseaseNational Cancer Institute (NCI)Phase 2
Deslorelin Combined With Low-Dose Add-Back Estradiol and Testosterone in Preventing Breast Cancer in Premenopausal Women Who Are at High Risk for This DiseaseCity of Hope Medical CenterPhase 2
Three Drug Combination Therapy Versus Conventional Treatment of Children With Congenital Adrenal HyperplasiaEunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)Phase 1

See all Deslorelin clinical trials

Clinical Trial Summary for Deslorelin

Top disease conditions for Deslorelin
Top clinical trial sponsors for Deslorelin

See all Deslorelin clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
McKinsey
Medtronic
Moodys
Harvard Business School
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.